Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 Topical Gel for Actinic Keratosis on the Head
NCT00700063Phase 2Completed
- Sponsor
- Peplin
- Start
- Jun 2008
- Primary completion
- Oct 2008
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Peplin. Started Jun 2008; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00700063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700063.